Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Fabian Stögbauer"'
Autor:
Katja Steiger, Nicole Pfarr, Bernhard Haller, Georg Philipp Schmidt, Peer-Hendrik Kuhn, Christine E Brambs, Moritz Jesinghaus, Jutta Engel, Wilko Weichert, Barbara Willvonseder, Melanie Boxberg, Holger Bronger, Gisela Keller, Fabian Stögbauer, Aurelia Noske
Publikováno v:
Cancer Immunology, Immunotherapy
Objective POLE-mutant, microsatellite-instable (MSI), p53-mutant and non-specific molecular profile (NSMP) are TCGA-defined molecular subgroups of endometrial cancer (EC). Hypothesizing that morphology and tumor immunology might differ depending on m
Autor:
Olaf Neumann, Anna-Lena Volckmar, Daniel Kazdal, Stefan Duensing, Michael Allgäuer, Jan Budczies, Peter Schirmacher, Martina Kirchner, Suranand Babu Talla, Fabian Stögbauer, Maximilian Jenzer, Eugen Rempel, Albrecht Stenzinger, Stefanie Zschäbitz, Constantin Schwab, Ildiko Kocsmar, Volker Endris
Publikováno v:
Genes, Chromosomes and Cancer. 59:406-416
Inflammatory gene signatures are currently being explored as predictive biomarkers for immune checkpoint blockade, and particularly for the treatment of renal cell cancers. From a diagnostic point of view, the nCounter analysis platform and targeted
Autor:
A Pickhard, Melanie Boxberg, Christof Winter, Fabian Stögbauer, Barbara Wollenberg, M Siegl, B Schmidl, Markus Wirth, D Jira
Publikováno v:
Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn.
Autor:
Steffen Ormanns, Martin E. Eichhorn, Jonas Leichsenring, Daniel Kazdal, Michael Allgäuer, Katharina Kriegsmann, Ludger Fink, Peter Schirmacher, Jan Budczies, Fabian Stögbauer, Anna-Lena Volckmar, Wilko Weichert, Arne Warth, Michael Thomas, Thomas Muley, Mark Kriegsmann, Rémi Longuespée, Albrecht Stenzinger, Martin Reck, Eugen Rempel, Petros Christopoulos, Jörg Kriegsmann, Felix J.F. Herth, Elke Kohlwes, Hauke Winter, Cristiano Oliveira, Kerstin Singer, Michael Leichsenring, Claus Peter Heußel, Alexander Harms, Luca Tavernar, Solange Peters
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Targeted genetic profiling of tissue samples is paramount to detect druggable genetic aberrations in patients with non-squamous non-small cell lung cancer (NSCLC). Accurate upfront estimation of tumor cell content (TCC) is a crucial pre-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66feca4e46042f29a177ff19c2055ab0
https://europepmc.org/articles/PMC8107748/
https://europepmc.org/articles/PMC8107748/
Autor:
Martina Kirchner, Jessica C. Hassel, Stefan Fröhling, Volker Endris, Ivo Buchhalter, Cristiano Oliveira, Roland Penzel, Peter Schirmacher, Alexander Enk, Albrecht Stenzinger, Fabian Stögbauer, Jonas Leichsenring, Anna-Lena Volckmar
Publikováno v:
Pathology. 50:703-710
Summary A deeper understanding of melanoma biology has opened up new avenues for mechanistically informed therapies. However, data on the prevalence of druggable genetic lesions in melanoma are still conflicting and real-world performance data on hig
Autor:
Bernhard Haller, Peer Kuhn, Markus Wirth, Melanie Boxberg, Ulrich Straßen, J. Budczies, Moritz Jesinghaus, Katja Steiger, Andreas Kolk, Konrad Klinghammer, Stephanie E. Combs, Hendrik Dapper, Fabian Stögbauer, Wilko Weichert, Stefan Münch, Björn Konukiewitz, Anja Pickhard, Aaron Becker von Rose, Miguel Silva
Publikováno v:
Br. J. Cancer 122, 835-846 (2020)
British Journal of Cancer
British Journal of Cancer
Background Pre-operative treatment planning in head and neck squamous cell carcinoma (HNSCC) is mainly dictated by clinical staging, which has major shortcomings. Histologic grading is irrelevant due to its lack of prognostic impact. Recently, a nove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b7d8037f9c5cb36a12373555392c2b9
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=57837
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=57837
Autor:
Peter Schirmacher, Fabian Stögbauer, Benjamin Goeppert, Volker Endris, Jonas Leichsenring, Michal R. Schweiger, Sebastian Klein, Anna Reiling, Albrecht Stenzinger, Tilmann Bochtler, Alwin Krämer
Publikováno v:
Journal of the National Comprehensive Cancer Network. 16:677-682
This case report presents a male patient with epithelioid mesothelioma that was initially misdiagnosed as cancer of unknown primary (CUP) and correctly identified using molecular panel sequencing. The patient had a prior history of colon and breast c
Autor:
Claudia Wickenhauser, Hanno Glimm, Jörn Rüssel, Barbara Klink, Lutz P. Müller, Karin Jordan, Stefan Fröhling, Albrecht Stenzinger, Hans-Jürgen Hurtz, Denis Terziev, Thomas Weber, Barbara Hutter, Fabian Stögbauer
Publikováno v:
European Journal of Haematology. 101:115-118
Recurrence of primary central nervous system lymphoma (PCNSL) after high-dose chemotherapy with autologous stem cell transplantation (ASCT) usually has a poor overall prognosis with limited treatment options. Data on repeated ASCT are sparse. Checkpo
Autor:
Pantelis Varvaki Rados, Kolja Freier, Daniela Richter, Amir Abdollahi, Matthias Bieg, Jochen Hess, Karim Zaoui, Adriana Jou, Stephanie E. Weissinger, Viny Shang, Nina D. Ullrich, Steffen Wagner, Christoph Plass, Jens Peter Klussmann, Thomas K. Hoffmann, Julia Thierauf, Roland Eils, Fabian Stögbauer, Britta Molfenter, Bianca De Bem Prunes, Wilko Weichert, Lea Schroeder, Michaela Plath, Naveed Ishaque, P.A. Federspil, Bouchra Tawk, Dana Holzinger, Fernanda Visioli, Claus Wittekindt, Natalia Koerich Laureano, Dieter Weichenhan, J Döscher, Xavier Pastor Hostench, Katrin Schmitt
Publikováno v:
International journal of cancerReferences. 145(12)
Genomic sequencing projects unraveled the mutational landscape of head and neck squamous cell carcinoma (HNSCC) and provided a comprehensive catalog of somatic mutations. However, the limited number of significant cancer-related genes obtained so far
Autor:
Volker Endris, Cathleen Nientiedt, Fabian Stögbauer, Carsten Grüllich, Dirk Jäger, Adam Kaczorowski, Markus Hohenfellner, Stefanie Zschäbitz, Holger Sültmann, Maximilian Jenzer, Brian Kudlow, Skyler Mishkin, Anna-Lena Volckmar, Peter Keß, Anette Duensing, Maximilian Kippenberger, Stefan Duensing, Josh Haimes, Peter Schirmacher, Albrecht Stenzinger, Jonas Leichsenring
Publikováno v:
Cancer Immunology, Immunotherapy
Defects in DNA damage repair caused by mutations in BRCA1/2, ATM or other genes have been shown to play an important role in the development and progression of prostate cancer. The influence of such mutations on anti-tumor immunity in prostate cancer